← Leaderboards
Lorraine J Gudas
Sloan-Kettering Institute For Cancer Res
$39,938,263
Attributed
$39,938,263
Total exposure
19
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$39,938,263 · 19
By mechanism
R01$25,023,623 · 10
T32$11,790,249 · 1
R21$1,336,730 · 3
P01$1,287,737 · 2
P50$499,924 · 1
P30$0 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularCellsRetinoidsPharmaceutical PreparationsAll-Trans-RetinolMalignant NeoplasmsLaboratoriesMouse ModelTretinoinTumorFundingGene ExpressionVitamin ACarcinogenesisGenesProteinsGrantSquamous Cell CarcinomaRetinoic Acid ReceptorResearch StudyCell TypePathologyGene TargetingStem Cells
Grant awards (124)
CD 1530, an RAR Gamma Agonist for Oral Cavity Squamous Cell Carcinoma Prevention$457,226
R01 · FY2025 · CA · contact PI
Gene Nutrient Interactions in Kidney Function$414,033
R01 · FY2025 · DK · contact PI
Cancer Pharmacology$506,020
T32 · FY2024 · CA · contact PI
CD 1530, an RAR Gamma Agonist for Oral Cavity Squamous Cell Carcinoma Prevention$434,366
R01 · FY2024 · CA · contact PI
Gene Nutrient Interactions in Kidney Function$397,471
R01 · FY2024 · DK · contact PI
Gene Nutrient Interactions in Kidney Function$98,635
R01 · FY2024 · DK · contact PI
Cancer Pharmacology$683,087
T32 · FY2023 · CA · contact PI
CD 1530, an RAR Gamma Agonist for Oral Cavity Squamous Cell Carcinoma Prevention$457,226
R01 · FY2023 · CA · contact PI
Gene Nutrient Interactions in Kidney Function$414,033
R01 · FY2023 · DK · contact PI
Gene Nutrient Interactions in Kidney Function$98,635
R01 · FY2023 · DK · contact PI
Cancer Pharmacology$651,936
T32 · FY2022 · CA · contact PI
Gene Nutrient Interactions in Kidney Function$414,033
R01 · FY2022 · DK · contact PI
Cancer Pharmacology$512,680
T32 · FY2021 · CA · contact PI
Gene Nutrient Interactions in Kidney Function$457,650
R01 · FY2021 · DK · contact PI
Career Enhancement Program (CEP)$97,709
P50 · FY2021 · CA · contact PI
(PQ1) Characterization of Premalignant Fields in a Murine Model of Head and Neck and Esophageal Cancers$566,168
R01 · FY2020 · CA · contact PI
Cancer Pharmacology$531,895
T32 · FY2020 · CA · contact PI
Gene Nutrient Interactions in Kidney Function$457,650
R01 · FY2020 · DK · contact PI
Uncovering the Role of Retinoic Acid Receptor Beta in Alcoholic Liver Diseases$201,281
R21 · FY2020 · AA · contact PI
Career Enhancement Program (CEP)$99,810
P50 · FY2020 · CA · contact PI
Cancer Pharmacology$505,811
T32 · FY2019 · CA · contact PI
Gene Nutrient Interactions in Kidney Function$457,650
R01 · FY2019 · DK · contact PI
(PQ1) Characterization of Premalignant Fields in a Murine Model of Head and Neck and Esophageal Cancers$450,331
R01 · FY2019 · CA · contact PI
Uncovering the Role of Retinoic Acid Receptor Beta in Alcoholic Liver Diseases$243,656
R21 · FY2019 · AA · contact PI
Career Enhancement Program (CEP)$97,710
P50 · FY2019 · CA · contact PI
(PQ1) Characterization of Premalignant Fields in a Murine Model of Head and Neck and Esophageal Cancers$96,981
R01 · FY2019 · CA · contact PI
Cancer Pharmacology$509,367
T32 · FY2018 · CA · contact PI
(PQ1) Characterization of Premalignant Fields in a Murine Model of Head and Neck and Esophageal Cancers$464,261
R01 · FY2018 · CA · contact PI
Gene Nutrient Interactions in Kidney Function$457,650
R01 · FY2018 · DK · contact PI
Career Enhancement Program (CEP)$105,066
P50 · FY2018 · CA · contact PI
Cancer Pharmacology$557,289
T32 · FY2017 · CA · contact PI
(PQ1) Characterization of Premalignant Fields in a Murine Model of Head and Neck and Esophageal Cancers$464,261
R01 · FY2017 · CA · contact PI
Oral Cancer Initiating Cells: Characterization$438,591
R01 · FY2017 · DE · contact PI
Career Enhancement Program (CEP)$99,629
P50 · FY2017 · CA · contact PI
Cancer Pharmacology$532,393
T32 · FY2016 · CA · contact PI
(PQ1) Characterization of Premalignant Fields in a Murine Model of Head and Neck and Esophageal Cancers$464,261
R01 · FY2016 · CA · contact PI
Oral Cancer Initiating Cells: Characterization$438,591
R01 · FY2016 · DE · contact PI
Oral Cancer Initiating Cells: Characterization$438,591
R01 · FY2015 · DE · contact PI
Cancer Pharmacology$422,841
T32 · FY2015 · CA · contact PI
Cancer Pharmacology$590,583
T32 · FY2014 · CA · contact PI
Diet and Alcohol Induced Epigenetic Changes in Oral Cavity Carcinogenesis Model$437,069
R01 · FY2014 · AA · contact PI
Oral Cancer Initiating Cells: Characterization$431,328
R01 · FY2014 · DE · contact PI
Squamous Cell Carcinomas - Effects of Retinoids$397,361
R01 · FY2014 · DE · contact PI
Cancer Pharmacology$572,148
T32 · FY2013 · CA · contact PI
Diet and Alcohol Induced Epigenetic Changes in Oral Cavity Carcinogenesis Model$419,047
R01 · FY2013 · AA · contact PI
Squamous Cell Carcinomas - Effects of Retinoids$381,467
R01 · FY2013 · DE · contact PI
Cellular Retinoic Acid Binding Proteins: Functional Studies$318,293
R01 · FY2013 · CA · contact PI
Alcohol-Induced Epigenetic Changes in Stem Cells$186,640
R21 · FY2013 · AA · contact PI
Cellular Retinoic Acid Binding Proteins: Functional Studies$98,725
R01 · FY2013 · CA · contact PI
Cancer Pharmacology$491,720
T32 · FY2012 · CA · contact PI
Diet and Alcohol Induced Epigenetic Changes in Oral Cavity Carcinogenesis Model$450,588
R01 · FY2012 · AA · contact PI
Squamous Cell Carcinomas - Effects of Retinoids$397,361
R01 · FY2012 · DE · contact PI
Cellular Retinoic Acid Binding Proteins: Functional Studies$338,610
R01 · FY2012 · CA · contact PI
Alcohol-Induced Epigenetic Changes in Stem Cells$242,938
R21 · FY2012 · AA · contact PI
Cellular Retinoic Acid Binding Proteins: Functional Studies$105,027
R01 · FY2012 · CA · contact PI
Cancer Pharmacology$576,995
T32 · FY2011 · CA · contact PI
Squamous Cell Carcinomas - Effects of Retinoids$458,253
R01 · FY2011 · DE · contact PI
Diet and Alcohol Induced Epigenetic Changes in Oral Cavity Carcinogenesis Model$365,496
R01 · FY2011 · AA · contact PI
Cellular Retinoic Acid Binding Proteins: Functional Studies$338,610
R01 · FY2011 · CA · contact PI
Diet and Alcohol Induced Epigenetic Changes in Oral Cavity Carcinogenesis Model$69,652
R01 · FY2011 · AA · contact PI
Cellular Retinoic Acid Binding Proteins: Functional Studies$68,425
R01 · FY2011 · CA · contact PI
Cancer Pharmacology$484,841
T32 · FY2010 · CA · contact PI
Squamous Cell Carcinomas - Effects of Retinoids$401,375
R01 · FY2010 · DE · contact PI
Diet and Alcohol Induced Epigenetic Changes in Oral Cavity Carcinogenesis Model$380,250
R01 · FY2010 · AA · contact PI
Cellular Retinoic Acid Binding Proteins: Functional Studies$349,083
R01 · FY2010 · CA · contact PI
Small Interfering RNAs: Inhibition of Oral Carcinogenesis in a Mouse Model$250,965
R21 · FY2010 · DE · contact PI
Cellular Retinoic Acid Binding Proteins: Functional Studies$68,750
R01 · FY2010 · CA · contact PI
Squamous Cell Carcinomas - Effects of Retinoids$52,804
R01 · FY2010 · DE · contact PI
CANCER PHARMACOLOGY$503,003
T32 · FY2009 · CA · contact PI
Cellular Retinoic Acid Binding Proteins: Functional Studies$349,083
R01 · FY2009 · CA · contact PI
Metabolism of Vitamin A in the Prostate$251,685
R01 · FY2009 · CA · contact PI
Small Interfering RNAs: Inhibition of Oral Carcinogenesis in a Mouse Model$211,250
R21 · FY2009 · DE · contact PI
CANCER PHARMACOLOGY$499,596
T32 · FY2008 · CA · contact PI
SQUAMOUS CELL CARCINOMAS - EFFECTS OF RETINOIDS$336,748
R01 · FY2008 · DE · contact PI
Metabolism of Vitamin A in the Prostate$251,685
R01 · FY2008 · CA · contact PI
CANCER PHARMACOLOGY$499,596
T32 · FY2007 · CA · contact PI
SQUAMOUS CELL CARCINOMAS - EFFECTS OF RETINOIDS$340,492
R01 · FY2007 · DE · contact PI
Retinoic Acid Binding Proteins: Functional Studies$339,916
R01 · FY2007 · CA · contact PI
Metabolism of Vitamin A in the Prostate$251,685
R01 · FY2007 · CA · contact PI
Retinoic Acid Binding Proteins: Functional Studies$62,894
R01 · FY2007 · CA · contact PI
CANCER PHARMACOLOGY$459,803
T32 · FY2006 · CA · contact PI
SQUAMOUS CELL CARCINOMAS - EFFECTS OF RETINOIDS$350,661
R01 · FY2006 · DE · contact PI
Retinoic Acid Binding Proteins: Functional Studies$350,068
R01 · FY2006 · CA · contact PI
Metabolism of Vitamin A in the Prostate$259,202
R01 · FY2006 · CA · contact PI
Metabolism of Vitamin A in the Prostate$89,389
R01 · FY2006 · CA · contact PI
Retinoic Acid Binding Proteins: Functional Studies$62,894
R01 · FY2006 · CA · contact PI
SQUAMOUS CELL CARCINOMAS - EFFECTS OF RETINOIDS$359,100
R01 · FY2005 · DE
Retinoic Acid Binding Proteins: Functional Studies$358,493
R01 · FY2005 · CA
CANCER PHARMACOLOGY$265,738
T32 · FY2005 · CA
Metabolism of Vitamin A in the Prostate$265,440
R01 · FY2005 · CA
Retinoic Acid Binding Proteins: Functional Studies$62,417
R01 · FY2005 · CA
Metabolism of Vitamin A in the Prostate$48,581
R01 · FY2005 · CA
SQUAMOUS CELL CARCINOMAS - EFFECTS OF RETINOIDS$359,100
R01 · FY2004 · DE
Retinoic Acid Binding Proteins: Functional Studies$358,493
R01 · FY2004 · CA
Retinoic Acid Binding Proteins: Functional Studies$34,901
R01 · FY2004 · CA
Retinoic Acid Binding Proteins: Functional Studies$358,493
R01 · FY2003 · CA
SQUAMOUS CELL CARCINOMAS--EFFECT OF RETINOIDS$346,707
R01 · FY2003 · DE
CANCER PHARMACOLOGY$345,130
T32 · FY2003 · CA
RETINOIC ACID--ROLE IN DIFFERENTIATION$417,818
R01 · FY2002 · CA
CANCER PHARMACOLOGY$359,247
T32 · FY2002 · CA
CELLULAR RETINOIC ACID BINDING PROTEIN--FUNCTIONAL STUDI$339,753
R01 · FY2002 · CA
SQUAMOUS CELL CARCINOMAS--EFFECT OF RETINOIDS$337,913
R01 · FY2002 · DE
VITAMIN A (RETINOL) AND 4 OXORETINOL IN BREAST CANCER$277,387
R01 · FY2002 · CA
ANIMAL MODELS OF AUTISM AND MECHANISMS OF INJURY$165,355
P01 · FY2002 · HD
ANIMAL MODELS OF AUTISM AND MECHANISMS OF INJURY$165,355
P01 · FY2002 · HD
CORE--RETINOID ANALYSIS$0
P30 · FY2002 · CA
RETINOIDS AND EPITHELIAL DIFFERENTIATION$0
P30 · FY2002 · CA
RETINOIC ACID--ROLE IN DIFFERENTIATION$408,411
R01 · FY2001 · CA
CANCER PHARMACOLOGY$374,728
T32 · FY2001 · CA
SQUAMOUS CELL CARCINOMAS--EFFECT OF RETINOIDS$328,108
R01 · FY2001 · DE
CELLULAR RETINOIC ACID BINDING PROTEIN--FUNCTIONAL STUDI$325,071
R01 · FY2001 · CA
VITAMIN A (RETINOL) AND 4 OXORETINOL IN BREAST CANCER$270,239
R01 · FY2001 · CA
ANIMAL MODELS OF AUTISM AND MECHANISMS OF INJURY$165,355
P01 · FY2001 · HD
RETINOIC ACID--ROLE IN DIFFERENTIATION$397,972
R01 · FY2000 · CA
CANCER PHARMACOLOGY$353,802
T32 · FY2000 · CA
CELLULAR RETINOIC ACID BINDING PROTEIN--FUNCTIONAL STUDI$325,071
R01 · FY2000 · CA
SQUAMOUS CELL CARCINOMAS--EFFECT OF RETINOIDS$318,591
R01 · FY2000 · DE
VITAMIN A (RETINOL) AND 4 OXORETINOL IN BREAST CANCER$263,294
R01 · FY2000 · CA
ANIMAL MODELS OF AUTISM AND MECHANISMS OF INJURY$262,145
P01 · FY2000 · HD
ANIMAL MODELS OF AUTISM AND MECHANISMS OF INJURY$262,145
P01 · FY2000 · HD
ANIMAL MODELS OF AUTISM AND MECHANISMS OF INJURY$165,355
P01 · FY2000 · HD
RETINOIDS AND EPITHELIAL DIFFERENTIATION$102,027
P01 · FY2000 · CA
ANIMAL MODELS OF AUTISM AND MECHANISMS OF INJURY$0
P01 · FY2000 · HD
RETINOIDS AND EPITHELIAL DIFFERENTIATION$0
P01 · FY2000 · CA